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Abstract
Background: The prevalence of mental illness in young people is the highest of any age group, with the onset of
depression, anxiety and substance use peaking between 18 and 24 years. Effective treatments that target sub-
threshold or mild to moderate levels of disorder in young people are required to reduce the risk of persistence
and recurrence. The aims of this study are to evaluate whether treatments that are less intensive than cognitive-
behaviour therapy, such as problem solving therapy and exercise treatments, are acceptable and effective in
managing depression and anxiety symptoms in young people and to identify possible attributes in those who are
likely to respond to these treatments.
Methods/design: This is a factorial randomised controlled trial conducted at a large, metropolitan youth mental
health service. Participants are young help-seekers aged 15-25 years with sub-threshold or mild to moderate levels
of depression and anxiety (with or without comorbid substance use). The interventions comprise 4 treatment
combinations delivered by psychologists over 6 sessions on a weekly basis: a psychological intervention (problem
solving therapy versus supportive counselling) and an exercise intervention (behavioural exercise versus
psychoeducation). Structured assessments occur at baseline, mid-point, end-point (6 weeks) and at a 6- and 12-
month follow-up. The primary outcomes are depression and anxiety symptoms as measured by the Beck
Depression and Anxiety Inventories. Secondary outcomes include remission (defined as no longer meeting the
diagnostic criteria for a disorder if threshold level was reached at baseline, or no longer scoring in the clinical
range on scale scores if sub-threshold at baseline), substance use, and functioning.
Discussion: The effectiveness of less complex psychological and exercise interventions in young help-seekers with
sub-threshold or mild to moderate presentations of high prevalence disorders is yet to be explored. This study has
been designed to examine the effectiveness of these interventions delivered alone, or in combination, in a youth-
specific service. If effective, the interventions have the potential to prevent the progression of early symptoms and
distress to later and potentially more serious stages of mental disorder and reduce the likelihood of ongoing
problems associated with the risk of persistence and recurrence.
Trial registration: Australian New Zealand Clinical Trials Registry ACTRN12608000550303
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The prevalence of mental disorders in young people is
the highest of any age group [1], with the onset of high
prevalence disorders such as depression, anxiety and sub-
stance use peaking within the age range of 18 to 24 years
[2]. There are many negative consequences, both
immediate and long-term, associated with mental disor-
ders, including impairments in social functioning, poor
education and employment attainment and achievement
[3-5], and increased risks of self-harm and suicide [6].
These outcomes do not solely occur in people with full-
threshold or severe forms of disorder; considerable
impairment in functioning is associated with what are
often referred to as ‘sub-threshold’ mental health pro-
blems, which are equally, if not more, prevalent [4,7,8].
Despite the prevalence and adverse outcomes of
experiencing mental health problems during adolescence
and young adulthood, young people are often reluctant
to seek help for mental health problems [9] and are the
least likely of all age groups to receive appropriate men-
tal health care [1,10]. To better facilitate the engagement
of young clients, services need to be youth-friendly,
delivered in a low-stigma setting and offer accessible
and acceptable interventions for young people [11,12]
that are developmentally appropriate [13,14]. Effective
treatments for this population that target early phases
or sub-threshold levels of disorder have the potential to
reduce the risk of persistence and recurrence [3,15,16],
and impairments in social, educational and vocational
functioning [3-5].
A potentially useful framework to guide treatment
decision-making is the clinical staging model for psychia-
tric disorders, which proposes matching specific inter-
ventions to specific stages of illness [17-19]. This model
is predicated on the notion that treatments delivered ear-
lier in the course of illness development will be safer and
more effective than those delivered later in the course of
more established illness, with earlier treatment poten-
tially preventing progression to more severe forms of dis-
order [17]. For example, milder, yet potentially serious
disorders at a sub-threshold or early stage may respond
to simple interventions such as psychosocial support,
self-help strategies and psycho-education, reserving more
intensive psychotherapy and/or pharmacotherapy for
later or more severe stages of illness. However, the
majority of studies that have contributed to the current
evidence base of interventions for young people with
depression and anxiety have included participants with
full-threshold levels of disorders (e.g., see [20-22] for sys-
tematic reviews). It remains unknown whether less com-
plex or intensive interventions, often used as control
conditions in treatment studies of more severe disorders,
would be feasible and effective treatments for those
experiencing milder or sub-threshold forms of mental
health problems.
The majority of psychological treatment trials for
young people with depression and/or anxiety disorders
have used cognitive-behaviour therapy (CBT), or adapta-
t i o n so ft h i st h e r a p y ,a st h ei n tervention [20,21]. These
trials have typically included participants with moderate
to severe full-threshold disorders of prolonged duration,
typified by the two major studies of psychological and
pharmacological therapies for depression; the Treatment
for Adolescent Depression (TADS; [23]) and the Adoles-
cent Depression Antidepressant and Psychotherapy Trial
(ADAPT; [24]). Brief forms of this therapy have rarely
been offered, with 12 sessions as standard [20] and most
trials have been based in specialist mental health set-
tings, making it unclear whether the intervention would
be feasible or acceptable for young people with mild to
moderate or sub-threshold forms of disorders who pre-
sent for treatment in primary or enhanced primary care
settings.
The multiple strategies in the mode of CBT dissemi-
nated in the TADS study has been criticised as being too
dense, with simpler models of CBT that focus on one or
two core components, such as behaviour activation and
problem solving, argued to be more beneficial [25]. Indeed,
a recent meta-analysis of psychotherapy for depressed
children and adolescents demonstrated that both cognitive
(i.e., CBT) and ‘non-cognitive’ (for example, behavioural
activation, family therapy, behavioural problem solving,
group support and social skills training) strategies were
equally effective in treating depression [21], suggesting
that the specific targeting of cognitions might not be a
necessary component of effective treatment in young peo-
ple [26]. Further, it has been argued that young people
appear to be more interested in treatment that offers them
ac h a n c et ob el i s t e n e dt oa n dto learn new skills rather
than develop a deeper understanding of the psychological
processes that contribute to their behaviour [27]. Com-
bined, these findings suggest the importance of exploring
alternative psychotherapies to CBT that may be more
acceptable and effective in younger populations with mild
to moderate or sub-threshold levels of disorder.
Given the concerns raised with the necessity of target-
ing cognitive distortions in young people and the difficul-
ties in disseminating CBT, we were interested in
exploring psychological interventions that were less com-
plex and could be delivered in a shorter number of ses-
sions. It was also of interest to explore interventions that
have the potential to be delivered in primary care set-
tings, which may be more appropriate settings for young
people with sub-threshold or mild to moderate high pre-
valence disorders. Furthermore, an overarching criticism
of interventions for young people with depression and
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occur with mental health problems tend to be overlooked
[26]. These health risk behaviours include substance use,
eating problems and low levels of regular physical activ-
ity. Interventions that can incorporate behavioural activa-
tion, such as problem solving therapy [28-30] and
exercise interventions [31], are beginning to be explored
as potentially effective interventions in reducing depres-
sion and anxiety symptoms in young people.
Problem solving therapy (PST) aims to assist a person
in learning to cope more effectively with their current
difficulties, as well as developing skills that can be used
in other settings and times in their life [32]. PST aims
to achieve this by systematically generating solutions to
current problems and implementing a structured plan
to resolve the difficulties, thereby introducing new beha-
viours and skills to effectively solve everyday problems
[33]. The therapy focuses on how to implement changes
in the ‘here and now’ rather than working through the
meaning and impact of past experiences [33,34]. Given
the relationship between stressful life events and the
e a r l yo n s e to fd e p r e s s i o n[ 3 5 ] ,P S Th a sf a c ev a l i d i t ya s
an intervention among young people. To date, its effec-
tiveness has been evaluated in two studies in this age
group. In 2008, Eskin and colleagues [29] randomly
assigned 46 self-referred high school or university stu-
dents (mean age 19 years) who met DSM-IV criteria
[36] for major depressive disorder to either PST (n =
27) or a wait-list control group (n = 19). At the end of
treatment, the 6 individual sessions of PST were more
effective than a wait-list control in reducing depression
symptoms and suicidal ideation, as well as increasing
assertiveness and self-esteem in this sample. These
changes were maintained at a 12-month follow-up
assessment. Arguably, changes in these constructs can
assist young people in negotiating and responding to
future challenges through the development of relevant
skills. Participants allocated to the PST intervention
attended all 6 sessions of the treatment, indicating that
it is an acceptable form of treatment for young people
with depression and suicidal ideation. However, the use
of a wait-list control group may be an inadequate com-
parison. It has been criticised because it only allows for
the control of the passage of time, but not for other
potential non-specific therapeutic factors, such as sup-
portive contact [37].
In an earlier and smaller trial by Lerner and Clum
(1990), group-based PST (n = 9) was compared with
supportive psychotherapy (n = 9) in young people
(mean age 19 years) who had suicidal ideation and self-
reported depressive symptoms, recruited through the
psychology department of a un i v e r s i t y[ 3 0 ] .T h ed e s i g n
had an appropriate condition to control for non-specific
therapeutic effects and each intervention consisted of
10 group sessions over a period of 5-7 weeks. PST was
more effective than supportive therapy in reducing
depressive symptoms and hopelessness, but suicidal
ideation decreased by a similar amount in both treat-
ment groups. Combined, these studies provide a preli-
minary evidence-base for using PST as an intervention
with younger populations, in particular young people
with depressive symptoms. Although Lerner and Clum’s
study contained 10 sessions, compared with the 6 used
by Eskin and colleagues, the duration of the interven-
tions were shorter than the average duration of CBT
(see [20]). This is consistent with a recent meta-analysis
of psychotherapy for depression in young people show-
ing no correlation between treatment duration and out-
come, indicating that briefer treatments may have a
similar effect to those of longer duration [21].
As mentioned above, health risk behaviours, including
low levels of physical activity, tend to be overlooked in
psychological interventions with young people, although
both mental health and physical health benefits have
been found [26]. Exercise interventions for those with
psychological difficulties are proposed to improve mood
by interrupting or distracting the person from dysfunc-
tional or negative thoughts and by the release of endor-
phins via strenuous exercise [38]. Weekly monitoring of
physical activity within psychotherapy sessions has been
found to be effective in reducing depression and anxiety
symptoms [39]. A key component of the success of
exercise interventions appears to be the encouragement
and assistance provided to participants to engage in reg-
ular physical activity, as well as benefits derived from
assessment and routine monitoring of daily levels of
exercise (e.g., see [40]).
Although based on a small number of trials of variable
quality, a systematic review of exercise interventions in
predominantly healthy children and young people found
positive short-term effects on self-esteem, with no
reported adverse effects [41]. A more recent systematic
review of exercise in the prevention and treatment of
depression and anxiety in children and young people
[31] found a small effect in favour of exercise, however,
again, the number of included trials was small and their
quality variable. Whether the exercise interventions
were of high or low intensity made little difference to
the outcomes. The evidence base for the effectiveness of
exercise interventions in children and young people who
are experiencing mental health problems is scarce as the
majority of trials have been conducted in healthy popu-
lations. Further high-quality studies are required to eval-
uate whether exercise is an effective treatment for
depression and anxiety in young people, particularly
those with emerging symptomatology.
Parker et al. Trials 2011, 12:76
http://www.trialsjournal.com/content/12/1/76
Page 3 of 8As noted above, it is essential to include an active con-
trol group when designing a treatment trial in order to
control for placebo or expectancy effects, or for the non-
specific effects of a therapeutic relationship [21]. We
believe this is also warranted when conducting studies in
clinical help-seeking populations. Control groups with
comparable intensity and duration of exposure to the
active treatment are essential in order to conclude that
the therapy is effective over and above the non-specific
therapeutic effects of compassion, attention, empathic lis-
tening and support [37,42]. Therefore, in psychotherapy
trials, control groups that offer a comparative amount of
supportive personal contact are superior to the use of a
wait-list control [37]. Supportive counselling (SC) has
often been used as a control condition in psychotherapy
trials in adult populations as a control for non-specific
relationships effects by offering non-directive, emotional
support through the establishment of a therapeutic alli-
ance based on empathic listening [43,44]. There has been
only one reported RCT in adolescents with major depres-
sive disorder receiving either CBT, family therapy or SC
[45]. CBT was the superior treatment in the shorter-term
outcome of symptom reduction, however, the long-term
outcomes over two years showed no differences between
the groups with regard to recovery, recurrence or level of
functioning, with the majority of participants recovering
during this time-frame [45]. Both the National Institute
for Health and Clinical Excellence (NICE) guidelines [46]
and the American Academy for Child and Adolescent
Psychiatry practice parameter [47] for treating children
and adolescents with depression recommend that those
with mild or brief depression initially be offered psychoe-
ducation and supportive counselling. As demonstrated in
an RCT of antidepressant medication and routine specia-
list care with and without CBT (the ADAPT study [24]),
a substantial proportion (21%) of child and adolescent
participants with moderate to severe major depression
responded to a brief intervention that was offered prior
to randomisation that included psychoeducation and
mental state monitoring, provided within an empathic
and supportive framework. As such, SC has face validity
as a suitable control condition for young people in the
early stages of mild to moderate depressive disorders.
In summary, there is emerging evidence to suggest
that PST and exercise interventions may have benefits
in reducing symptoms of mental distress, particularly
depression, in younger populations, although there is a
need for further research that utilises adequate control
conditions. It is also of interest to explore the effects of
less complex or intense interventions separately and
whether there are additional benefits gained from deli-
vering the interventions together.
Methods/Design
Study objectives
The primary aims are to evaluate whether simple psy-
chological and exercise treatments are effective for treat-
ing sub-threshold or mild to moderate depression and
anxiety disorders in young people and, if so, which
interventions (or their combination) are most effective
for various types or severities of clinical presentations. A
secondary aim is to identify possible attributes of those
who are likely to respond to less-complex interventions.
It is hypothesised that the active interventions of PST
and behavioural exercise will be more effective than the
control conditions of supportive counselling and lifestyle
psychoeducation in: a) reduction of symptoms of
depression and anxiety; b) reduction of substance use; c)
improvement in functioning; and d) leading to the
remission of depression and anxiety (using either diag-
nostic thresholds or scale scores, depending on baseline
symptomatology). We further hypothesise that: e) the
combination of active interventions (that is, PST and
behavioural exercise) will lead to a greater reduction in
symptoms of depression and anxiety than the combina-
tion of control interventions (SC and lifestyle
psychoeducation).
Study design
The study is a factorial RCT (see [48]), as this design allows
for multiple interventions to be assessed against appropri-
ate control interventions in the framework of a single trial
[48,49] (see Table 1). A factorial design also allows the pos-
sibility of considering the effects of both the interventions
separately and the effects of delivering the interventions
together [48]. It is registered as ACTRN12608000550303
with the Australian New Zealand Clinical Trials Registry
and has been approved by the Melbourne Health Human
Research and Ethics Committee.
Setting
headspace Western Melbourne (WM) is a youth mental
health service that provides assessment and psychologi-
cal and/or psychiatric treatments to young people aged
12-25 years, in addition to primary health care, voca-
tional and educational assistance and specialist sub-
stance use services. These services are delivered in a
“one-stop shop”, youth-friendly service environment
staffed by general practitioners, psychologists, psychia-
trists and other allied health professionals, located in the
urban Western region of Melbourne, Australia. The
headspace WM catchment area has a population of 452
762, of which 76 791 are aged 12-24 years. The service
is led by a consortium of partners managed by Orygen
Youth Health Research Centre.
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All help-seeking young people aged 15-25 years who
present or are referred to headspace WM and are on
the waiting list are screened for suitability on the basis
of study inclusion criteria, with informed consent
obtained from all participants. Those under 15 years are
excluded, as obtaining parental/guardian consent can be
problematic for young people who do not wish to
involve their caregivers in seeking help for mental health
problems. Inclusion criteria are: depressive/anxious
symptoms of more than one week’sd u r a t i o no ra
decline in functioning over the past month, and no
prior formal treatment (e.g., psychological intervention
provided by a registered psychologist or pharmacother-
apy of at least 4 weeks’ duration). Exclusion and with-
drawal criteria are: psychotic symptoms and/or specific
suicidal plan or intent; already exercising according to
Australian government guidelines (i.e., daily moderate to
vigorous exercise of 60 minutes duration for under 18
years; four times per week of 30 minutes of moderate to
vigorous exercise for those over 18 years [50,51]);
organic mental disorder; intellectual disability. Based on
power calculations (see below), we aim to recruit 160
participants between April 2009 and July 2011.
Procedure
After assessing eligibility, a research assistant contacts
the young person by telephone to explain the study and
offer an appointment for the purpose of obtaining
informed consent. Following the provision of informed
consent, the research assistant conducts the baseline
assessment.
Participants are allocated to their treatment combina-
tion prior to the first treatment session with a research
psychologist (see randomisation procedure below). At
the first treatment session, participants are provided
with the relevant psychoeducation materials and
resources. During each treatment session, participants’
mental state is monitored for the purposes of withdra-
wal criteria. Treatment continues for the duration of the
trial unless the participant is withdrawn due to worsen-
ing symptoms that reach threshold level, using the
expanded Brief Psychiatric Rating Scale version 4
(ExBPRS; [52]). Threshold levels of severe symptoms
and disruption to functioning have been defined as: a
score ≥6 on exBPRS Anxiety and Depression subscales
or a score of ≥5 on exBPRS Suicidality subscale, main-
tained for one week; a score ≥5 on exBPRS subscales of
hallucinations, suspiciousness, or unusual thought con-
tent, and exBPRS score ≥4 on conceptual disorganisa-
tion; or the clinical necessity of introducing
antidepressant or anxiolytic medication due to distress
associated with ongoing symptoms. At the end of the 6
sessions, participants who have not responded or are in
need of further clinical intervention are referred to
treatment as usual within headspace WM, or to another
appropriate service.
Structured assessments occur at baseline, mid-point
(3 weeks), end-point (6 weeks), and at a 6- and
12-month follow-up.
Interventions
The interventions are delivered in 6 sessions on a
weekly basis by research psychologists and involve a
combination of:
a) Psychological intervention: problem solving ther-
apy (PST; active condition) or supportive counselling
(control condition), AND
b) Exercise intervention: behavioural intervention
(active condition) or psychoeducation (control
condition).
A comprehensive treatment manual for each interven-
tion has been prepared. The PST intervention progres-
sively works through the seven steps of PST, namely (1)
identifying the young person’s problem/s; (2) selecting one
or two key problems; (3) identifying goals; (4) generating
solutions; (5) choosing a solution; (6) creating a SMART
(specific, measurable, achievable, relevant, time-limited)
Table 1 Factorial RCT study design
Exercise intervention
Exercise psychoeducation
(control condition)
Behavioural exercise
(active condition)
Psychological
intervention
Supportive counselling
(control condition)
n = 40 n = 40 N = 80 Principal psychological
comparison
Problem solving therapy
(active condition)
n = 40 N = 40 N = 80
N=8 0 N=8 0
Principal exercise comparison
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The supportive counselling intervention is based on gen-
eral counselling principles [44] and is guided by the NICE
guidelines for young people with mild to moderate depres-
sion [46]. The behavioural exercise intervention assists
participants in meeting the Australian guidelines for physi-
cal activity [50,51] via a process of identifying barriers and
strengths for engaging in regular exercise and monitoring
physical activities. Participants are provided with psychoe-
ducation on the relationship between exercise and mood/
anxiety symptoms, along with exercise diaries and ped-
ometers to record and encourage regular activity.
An important consideration f o rf a c t o r i a ld e s i g n si st h e
feasibility of delivering the interventions together [48].
The interventions were piloted in headspace WM with a
small group of young help-seekers, and were shown to be
acceptable and feasible interventions in this population.
Outcomes and measures
Primary outcome
Depression and anxiety symptoms at the end of treat-
ment and the follow-up points.
Primary outcome measures
Beck Depression Inventory-II (BDI-II [53]), Beck Anxi-
ety Inventory (BAI [54]), and Montgomery Åsberg
Depression Rating Scale (MADRS [55]).
Secondary outcomes
(i) improvement on clinical and self-report measures of
symptoms and substance use; (ii) remission (defined as
no longer meeting the diagnostic criteria for a disorder
if threshold level was reached at baseline, or no
longer scoring in the clinical range on scale scores if
sub-threshold at baseline); (iii) social and occupational
functioning; (iv) exercise frequency and duration; (v)
treatment satisfaction; and (vi) any additional treatment
post-intervention.
Secondary outcome measures
(i) Beck Suicide Inventory, Substance and Choices Scale
[56], and the Comprehensive Assessment of At-Risk
Mental States (CAARMS [57]); (ii) the Structured Clini-
cal Interview for DSM-IV Axis I disorders (SCID-I; [58])
or the clinical range on scale scores on MADRS (<12),
BDI-II (<13) and BAI (<9), depending on diagnostic
threshold levels at baseline; (iii) Social and Occupational
Functional Scale [59]; (iv) weekly physical activities
based on the Active Australia Survey [60]; (v) experience
of treatment questionnaire (based on [61]); (vi) addi-
tional treatment questionnaire assessing any treatment
(psychological, pharmacological, or alternate) between
endpoint and the follow-up periods.
Randomisation and treatment allocation
The randomisation schedule was devised by an indepen-
dent statistician (AM). Allocation to treatment is
concealed as it is carried out by an independent
researcher not involved in conducting the interventions
or the participant assessments, in accordance with ICH
Guideline E9 [62]. Participants are randomised to one of
four possible combinations of interventions. The inde-
pendent researcher contacts the research psychologist
after the baseline assessment and prior to the first treat-
ment session to inform them of each participant’st r e a t -
ment allocation. It is not possible to blind the research
psychologists and participants to the treatment alloca-
tion. All baseline and outcome assessments are, how-
ever, conducted by research assistants blinded to
treatment allocation.
A stratified randomisation design is used to incorporate
characteristics of sex (2 level factor) and symptom severity
at baseline (2 level factor: BDI-II cut-off points; ≤28 mild/
moderate or ≥29 severe) since any chance imbalances on
these variables may prejudice the analyses. Participants are
allocated to the treatment groups using randomly per-
muted blocks within each stratum, to ensure that alloca-
tion to treatment groups is approximately equal.
Statistical analyses
Primary analyses will be conducted on an intent-to-treat
basis, including all participants randomised regardless of
treatment actually received or withdrawal from the
study. Mixed-model repeated measures analyses will be
used, as this approach enables the inclusion of partici-
pants with missing data, without using inferior techni-
ques such as last observation carried forward [63]. For
analyses of binary, ordinal and categorical outcomes,
non-linear mixed modelling will be used. Subsidiary
analyses will explore participant characteristics that
moderate outcome.
Power analysis
Based on a correlation of 0.7 between baseline and end-
point observations, and allowing for 30% attrition, a sam-
ple size of 160 (40 participants in each cell) will maintain
power above 75% to detect effects of 0.5 standard devia-
tions change between active and comparison treatments.
Beyond the detection of substantial sub-additivity of
effects of the interventions, it is recognised that power to
differentiate the effectiveness of specific combinations of
treatments will not be high. When testing for predictors
of effectiveness for individual treatment arms, the study
will have 75% power to detect simple relations below r =
0.33 allowing for 30% attrition. The sample size will
allow for multivariate analyses with up to 3 predictors,
assuming moderate size effects (see [64]).
Discussion
Whilst preliminary, the emerging evidence-base suggests
that simple and less intensive interventions that include
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reducing depression and anxiety related symptoms. This
paper has outlined a factorial randomised controlled
trial that has been specifically designed to test the
effectiveness of simple psychological and exercise inter-
ventions in young people with sub-threshold or mild-
moderate depressive or anxiety disorders, with possible
comorbid substance use. The project also aims to iden-
tify attributes to determine which clinical presentations
are most suitable for simple interventions delivered in a
youth mental health service. If effective, the interven-
tions have the potential to prevent the progression of
early stages to later and potentially more serious stages
of illness and to reduce the likelihood or ongoing pro-
blems associated with risk of persistence and recurrence.
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